Ireland attracting fewer clinical trials than some European countries
Irish Pharmaceutical Healthcare Association
Waiving patent rights may have chilling effect on medicine development, industry warns
Industry says waiver of IP rights not needed as vaccine supply far outweighs demand
Just half of 41 cancer drugs approved from 2017-2020 were available here at end of 2021
Spending review says that confidential pricing deals make it more difficult for HSE to contain drug costs
Medicines regularly not worth approving at asking price
Upfront costs high but treatments may cut long-term expense and boost patient results
Company recorded 80 per cent increase in pretax profit to €8.59 million in 2019
New medicines have cut number of years of life lost to heart disease by 34% since 2005
Most Read
You may also like...
Crosswords & puzzles to keep you challenged and entertained
Start The Search For Your Next Job
Audio versions of the best journalism from The Irish Times